CAN WE PREDICT WHO WILL DEVELOP IPILIMUMAB-INDUCED HYPOPHYSITIS? – A LARGE COHORT STUDY IN PATIENTS WITH METASTATIC MELANOMA TREATED AT A SINGLE ACADEMIC CENTER

Abstract

Peer reviewed

Roula Zahr, Daniel Chakos, Yousef Zakharia, Emile Latour, Yiyi Chen and Maria Fleseriu

Endocrine practice, Vol.24, pp.192-193

04/01/2018

View Online

abstract only

Cohort Analysis

Immunotherapy

Metastasis

Monoclonal Antibodies

Autoimmune diseases

Cancer therapies

Males

Melanoma

Targeted cancer therapy

Title: Subtitle: CAN WE PREDICT WHO WILL DEVELOP IPILIMUMAB-INDUCED HYPOPHYSITIS? – A LARGE COHORT STUDY IN PATIENTS WITH METASTATIC MELANOMA TREATED AT A SINGLE ACADEMIC CENTER
Creators: Roula Zahr
Daniel Chakos
Yousef Zakharia
Emile Latour
Yiyi Chen
Maria Fleseriu
Resource Type: Abstract
Publication Details: Endocrine practice, Vol.24, pp.192-193
Publisher: Elsevier Limited
ISSN: 1530-891X
eISSN: 1934-2403
Language: English
Date published: 04/01/2018
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984548266002771

4 Record Views